Fig. 5From: Efficacy and safety analyses of epidermal growth factor receptor tyrosine kinase inhibitors combined with chemotherapy in the treatment of advanced non–small-cell lung cancer with an EGFR/TP53 co-mutationForest plot for TTP and OS of EGFR/TP53 co-mutation patients treated with T or TCBack to article page